INTRODUCTION: Urinary continence significantly affects quality of life after radical prostatectomy (RP). The impact of nerve-sparing surgery on continence is unclear from the current literature. METHODS: We identified men with prostate cancer from the University Health Network Prostate Centre database who underwent RP. Preoperatively and at each postoperative visit, patients completed the Patient-Oriented Prostate Utility Scale (PORPUS), a validated psychometric and health utility instrument. Incontinence was defined by a single questionnaire item. Patients with radiotherapy or less than 10 months follow-up were excluded. Chi-squared tests and ANOVA were used to compare groups. Multivariable logistic regression was used to control for effects of nerve-sparing and other covariates. RESULTS: Of the 253 eligible patients from 2003 to 2007, 159 patients had bilateral nerve-sparing, 32 had unilateral nerve-sparing and 62 had non-nerve-sparing surgery. Of these patients, 27%, 17% and 34%, respectively, were classified as incontinent at 1 year. These proportions were not significantly different between groups (p = 0.23). Multivariable logistic regression showed baseline urinary continence and urinary frequency to be significant predictors of patient-reported continence at 1 year postoperatively, with odds ratios of 1.7 (95% confidence interval [CI] 1.1-2.9) and 1.5 (95% CI 1.0-2.3), respectively. There was a significant difference in the proportion of PORPUS sexual function scores between nerve-sparing groups after excluding those with baseline sexual dysfunction (p = 0.003). Similarly, health-related utility scores were different across groups (p < 0.001). CONCLUSION: Our results do not suggest a difference in 1-year patient-reported continence based on the type of nerve-sparing RP. However, baseline continence and urinary frequency were significant predictors of continence at 1 year.
INTRODUCTION: Urinary continence significantly affects quality of life after radical prostatectomy (RP). The impact of nerve-sparing surgery on continence is unclear from the current literature. METHODS: We identified men with prostate cancer from the University Health Network Prostate Centre database who underwent RP. Preoperatively and at each postoperative visit, patients completed the Patient-Oriented Prostate Utility Scale (PORPUS), a validated psychometric and health utility instrument. Incontinence was defined by a single questionnaire item. Patients with radiotherapy or less than 10 months follow-up were excluded. Chi-squared tests and ANOVA were used to compare groups. Multivariable logistic regression was used to control for effects of nerve-sparing and other covariates. RESULTS: Of the 253 eligible patients from 2003 to 2007, 159 patients had bilateral nerve-sparing, 32 had unilateral nerve-sparing and 62 had non-nerve-sparing surgery. Of these patients, 27%, 17% and 34%, respectively, were classified as incontinent at 1 year. These proportions were not significantly different between groups (p = 0.23). Multivariable logistic regression showed baseline urinary continence and urinary frequency to be significant predictors of patient-reported continence at 1 year postoperatively, with odds ratios of 1.7 (95% confidence interval [CI] 1.1-2.9) and 1.5 (95% CI 1.0-2.3), respectively. There was a significant difference in the proportion of PORPUS sexual function scores between nerve-sparing groups after excluding those with baseline sexual dysfunction (p = 0.003). Similarly, health-related utility scores were different across groups (p < 0.001). CONCLUSION: Our results do not suggest a difference in 1-year patient-reported continence based on the type of nerve-sparing RP. However, baseline continence and urinary frequency were significant predictors of continence at 1 year.
Authors: Fiona C Burkhard; Thomas M Kessler; Achim Fleischmann; George N Thalmann; Martin Schumacher; Urs E Studer Journal: J Urol Date: 2006-07 Impact factor: 7.450
Authors: Paul Ritvo; Jane Irvine; Gary Naglie; George Tomlinson; Andrea Bezjak; Andrew Matthew; John Trachtenberg; Murray Krahn Journal: J Clin Epidemiol Date: 2005-05 Impact factor: 6.437
Authors: J A Talcott; P Rieker; K J Propert; J A Clark; K I Wishnow; K R Loughlin; J P Richie; P W Kantoff Journal: J Natl Cancer Inst Date: 1997-08-06 Impact factor: 13.506
Authors: Martin G Sanda; Rodney L Dunn; Jeff Michalski; Howard M Sandler; Laurel Northouse; Larry Hembroff; Xihong Lin; Thomas K Greenfield; Mark S Litwin; Christopher S Saigal; Arul Mahadevan; Eric Klein; Adam Kibel; Louis L Pisters; Deborah Kuban; Irving Kaplan; David Wood; Jay Ciezki; Nikhil Shah; John T Wei Journal: N Engl J Med Date: 2008-03-20 Impact factor: 91.245
Authors: Daniel Santa Mina; Crissa L Guglietti; Shabbir M H Alibhai; Andrew G Matthew; Robin Kalnin; Nora Ahmad; Uri Lindner; John Trachtenberg Journal: J Cancer Surviv Date: 2013-12-07 Impact factor: 4.442
Authors: Eva M Zopf; Moritz Braun; Stefan Machtens; Jürgen Zumbé; Wilhelm Bloch; Freerk T Baumann Journal: BMC Cancer Date: 2012-07-24 Impact factor: 4.430
Authors: Daniel Santa Mina; Darren Au; Shabbir M H Alibhai; Leah Jamnicky; Nelly Faghani; William J Hilton; Leslie E Stefanyk; Paul Ritvo; Jennifer Jones; Dean Elterman; Neil E Fleshner; Antonio Finelli; Rajiv K Singal; John Trachtenberg; Andrew G Matthew Journal: BMC Urol Date: 2015-09-16 Impact factor: 2.264
Authors: Olga Dolejsova; Radek Kucera; Radka Fuchsova; Ondrej Topolcan; Hana Svobodova; Ondrej Hes; Viktor Eret; Ladislav Pecen; Milan Hora Journal: Technol Cancer Res Treat Date: 2018-01-01